Em+ Elisa: a serological test able to predict long term outcome in inoperable alveolar echinococcosis patients under benzimidazole therapy

Carine Richou (1, 2) , Frédéric Grenouillet (1, 3) , Eric Delabrousse (1) , Oleg Blagosklonov (1, 4) , Shu Mei Ma (1) , Laurence Millon (3) , Georges André Mantion (1) , Vincent Di Martino (5) , Solange Bresson-Hadni (1, 3)

1 WHO Collaborating Center on Prevention and Treatment of Human Echinococcosis
2 CHRU Besançon - Centre Hospitalier Régional Universitaire de Besançon
3 LCE - Laboratoire Chrono-environnement (UMR 6249)
4 Service de Médecine nucléaire, biophysique, isotopes [CHRU Besançon]
5 API - Agents pathogènes et inflammation - UFC (EA 4266)

Domaines: Mycologie

Carine Richou, Frédéric Grenouillet, Eric Delabrousse, Oleg Blagosklonov, Shu Mei Ma, et al.. Em+ Elisa: a serological test able to predict long term outcome in inoperable alveolar echinococcosis patients under benzimidazole therapy. Gastro2009 UEGW/WCOG, Nov 2009, London, United Kingdom. pp.A195. ⟨hal-00485055⟩